Sjoukje I. Lok - Concepedia

Author

Sjoukje I. Lok

University Medical Center Utrecht

Also Known As

S. I. Lok, S. Lok, S.I. Lok, Sjoukje I Lok, Sjoukje I. Lok

Publications

884

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Maastricht University University Medical Center Groningen Deventer Ziekenhuis Royal Netherlands Academy of Arts and Sciences

About

Sjoukje I. Lok is an author at University Medical Center Utrecht specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	388
2	Natural Sciences	1	1	67
3	Public Health	1	1	14
4	Biochemistry	1	1	67
5	Cell Biology	1	1	67

Sjoukje I. Lok

Publications

863

Citations

H-Index

Page 1

	Year	Citations
Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure Dirk J. Lok, Sjoukje I. Lok, Pieta W. Bruggink‐André de la Porte, Clinical Research in Cardiology CardiomyopathyHeart FailureChronic Heart FailureCardiovascular DiseaseIndependent Marker	2012	212
Circulating Growth Differentiation Factor-15 Correlates with Myocardial Fibrosis in Patients with Non-Ischaemic Dilated Cardiomyopathy and Decreases Rapidly After Left Ventricular Assist Device Support Sjoukje I. Lok, Björn Winkens, Roel Goldschmeding, European Journal of Heart Failure	2012	148
A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart Stefanos Leptidis, Hamid el Azzouzi, Sjoukje I. Lok, PLoS ONE	2013	100
Incremental Prognostic Power of Novel Biomarkers (Growth-Differentiation Factor-15, High-Sensitivity C-Reactive Protein, Galectin-3, and High-Sensitivity Troponin-T) in Patients With Advanced Chronic Heart Failure Dirk J. Lok, IJsbrand T. Klip, Sjoukje I. Lok, The American Journal of Cardiology Prognostic BiomarkersHeart FailureTranslational MedicineCardiovascular DiseaseBiomarkers	2013	95
Stanniocalcin 2: Characterization of the Protein and its Localization to Human Pancreatic Alpha Cells Emma Moore, Rolf Kuestner, Darrell Conklin, Hormone and Metabolic Research Pancreas TransplantationCellular PhysiologyGastrointestinal Peptide HormonePancreatic CancerNative Hamster	1999	67
Prognostic Value of N-Terminal Pro C-Type Natriuretic Peptide in Heart Failure Patients with Preserved and Reduced Ejection Fraction Dirk J. Lok, IJsbrand T. Klip, Adriaan A. Voors, European Journal of Heart Failure	2014	52
Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support Sjoukje I. Lok, Fay M. A. Nous, Joyce van Kuik, European Journal of Cardio-Thoracic Surgery	2015	52
Single-centre experience of 85 patients with a continuous-flow left ventricular assist device: clinical practice and outcome after extended support Sjoukje I. Lok, Jerson R. Martina, Tim Hesselink, European Journal of Cardio-Thoracic Surgery	2013	27
Functional and Haemodynamic Recovery After Implantation of Continuous-Flow Left Ventricular Assist Devices in Comparison with Pulsatile Left Ventricular Assist Devices in Patients with End-Stage Heart Failure R.V. Pruijsten, Sjoukje I. Lok, Hans H. Kirkels, European Journal of Heart Failure	2012	26
Post-transcriptional Regulation of α-1-Antichymotrypsin by MicroRNA-137 in Chronic Heart Failure and Mechanical Support Sjoukje I. Lok, Alain van Mil, Niels Bovenschen, Circulation Heart Failure	2013	25

Page 1